Home > Balance Sheet > NATCO PHARMA

NATCO PHARMA
Contingent Liabilities

    Back to Balance Sheet
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹0.40 Cr₹15 Cr₹8.00 Cr₹1.20 Cr₹1.10 Cr

What is the latest Contingent Liabilities ratio of NATCO PHARMA ?

The latest Contingent Liabilities ratio of NATCO PHARMA is ₹0.40 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹0.40 Cr
Mar2023₹15 Cr
Mar2022₹8.00 Cr
Mar2021₹1.20 Cr
Mar2020₹1.10 Cr

How is Contingent Liabilities of NATCO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹0.40 Cr
-97.26
Mar2023 ₹15 Cr
82.50
Mar2022 ₹8.00 Cr
566.67
Mar2021 ₹1.20 Cr
9.09
Mar2020 ₹1.10 Cr -

Compare Contingent Liabilities of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹15,070.4 Cr -5.8% 3.6% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,778.0 Cr 1.4% 4.1% 18.7% Stock Analytics
DIVIS LABORATORIES ₹161,949.0 Cr -2.1% 4.2% 59.1% Stock Analytics
CIPLA ₹123,222.0 Cr -0.1% 5% 9.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,205.0 Cr -0.3% 3% 23.4% Stock Analytics
DR REDDYS LABORATORIES ₹98,707.7 Cr -1.5% 1.7% -5.4% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

-5.8%

3.6%

-13.6%

SENSEX

0.9%

4.2%

8.3%


You may also like the below Video Courses